Gossamer Bio Inc (GOSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2018 | 03-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -58,773 | -26,037 | -6,771 | -83 |
| Depreciation Amortization | 38 | 6 | 0 | 0 |
| Accounts payable and accrued liabilities | 783 | 546 | N/A | N/A |
| Other Working Capital | 4,852 | 820 | 994 | 103 |
| Other Operating Activity | 42,594 | 20,957 | 32 | 0 |
| Operating Cash Flow | $-10,506 | $-3,708 | $-5,745 | $20 |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | -20,002 | N/A | N/A | N/A |
| PPE Investments | -1,452 | -511 | 0 | 0 |
| Other Investing Activity | -9,460 | 11,176 | 0 | 0 |
| Investing Cash Flow | $-30,914 | $10,665 | $0 | $0 |
| Cash Flows From Financing Activities | ||||
| Debt Repayment | -40 | -40 | N/A | N/A |
| Other Financing Activity | 73,491 | 71,944 | 6,000 | 40 |
| Financing Cash Flow | $73,451 | $71,904 | $6,000 | $40 |
| Beginning Cash Position | 315 | 315 | 60 | 60 |
| End Cash Position | 32,346 | 79,176 | 315 | 60 |
| Net Cash Flow | $32,031 | $78,861 | $255 | $60 |
| Free Cash Flow | ||||
| Operating Cash Flow | -10,506 | -3,708 | -5,745 | 20 |
| Capital Expenditure | -1,452 | -511 | N/A | N/A |
| Free Cash Flow | -11,958 | -4,219 | -5,745 | 20 |